Literature DB >> 25287029

Out-patient percutaneous renal biopsy among children in Northern Nigeria: a single center experience.

Patience N Obiagwu1, Aliyu Abdu, Akinfenwa T Atanda.   

Abstract

BACKGROUND: The safety of percutaneous renal biopsy (PRB) has been debated. The primary aim of this study was to review the procedure and secondary aim is to evaluate the safety of PRB in children in a developing nephrology unit in Northern Nigeria.
METHODS: Renal biopsies carried out in the renal unit of a teaching hospital in northern Nigeria between November 2011 and April 2013 were retrospectively reviewed. All biopsies were carried out electively and under real-time ultrasound guidance using an automatic spring-loaded biopsy gun. Risk factors for complications were analyzed using logistic regression.
RESULTS: A total of 24 biopsies were carried out in 20 children with nephrotic syndrome during the period under review. Mean age was 8.3 ΁ 3.0 years. Steroid resistant nephrotic syndrome was the most common indication for biopsy in 11 (55%) cases. Adequate tissue was obtained in 91.7%. Complications occurred in 2 (8.3%) cases. One required hospitalization with blood transfusion. Pre-biopsy hemoglobin concentration of <10 g/dL was found to be a significant predictor for the development of complications (P < 0.05). There was no significant difference in the rate of complications between the in-patient biopsies and day case biopsies.
CONCLUSIONS: PRB can be safely carried out as an out-patient procedure in children. Low hemologlobin concentration was the major risk factor for complication.

Entities:  

Mesh:

Year:  2014        PMID: 25287029     DOI: 10.4103/1596-3519.142286

Source DB:  PubMed          Journal:  Ann Afr Med        ISSN: 0975-5764


  1 in total

1.  Safety and Adequacy of Ultrasound-Guided Percutaneous Renal Biopsy in Children: A Single-Center Experience.

Authors:  Kausar Illahi Bux; Khemchand N Moorani; Hina Qureshi; Usha Kumari; Faheemullah Khan; Faryal Farooq; Fakhar Abbas; Muhammad Aman; Abdul Moiz Sahito; Faisal Musharraff; Muhammad Sami Alam
Journal:  Cureus       Date:  2022-04-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.